Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae | Zendy

Maria Loose | Zendy; Isabell Link | Zendy; Kurt G. Naber | Zendy; Flo﻿ri﻿an Wagenlehner | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Enterobacteriaceae

Author(s) -

Maria Loose,

Isabell Link,

Kurt G. Naber,

Florian Wagenlehner

Publication year - 2019

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01839-19

Subject(s) - enterobacteriaceae , carbapenem , antibiotics , microbiology and biotechnology , carbapenem resistant enterobacteriaceae , respiratory tract infections , urinary system , medicine , biology , respiratory system , escherichia coli , biochemistry , gene

The increasing global prevalence of carbapenem-resistantEnterobacteriaceae (CRE) combined with the decline in effective therapies is a public health care crisis. After respiratory tract infections, urinary tract infections and associated urosepsis are the second most affected by CRE pathogens.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research